Under construction – not a live service
Sign in
Taking people in FranceNo phase

Everyday Experiences of People Using Arm Assistance Devices After Stroke or Other Conditions

Gathers views of adults who already use arm assistance devices at home.

Plain-language title generated from the registry record
Registry title: Impact Study on Users of Upper Limb Assistive Devices

Key facts

Where
Perpignan and Ploemeur, FranceSee the 2 sites

Where in France

  • Centre Bouffard VercelliPerpignan, FranceTaking people
  • Centre de KerpapePloemeur, FranceTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
Association APPROCHE
Trial code
NCT07429188
Record updated
24 February 2026
Original description
This impact study of upper limb (UL) assistance devices is part of the Exploratory PEPR O2R "Robotic assistance for human movements." The integrated project PI3 "ASSISTMOV," composed of a multidisciplinary team in engineering and Human and Social Sciences (HSS), targets the use case of employing robotic assistance for the movement of persons with disabilities (PWD). Through the development of a range of exoskeletons (lower and upper limbs), this project aims for a breakthrough technology enabling fluid and robust interaction with a variety of environments and uses (from rehabilitation to daily life).Read full original descriptionShow less

Impact Study on Users of Upper Limb Assistive Devices (AMUSE)

This impact study of upper limb (UL) assistance devices is part of the Exploratory PEPR O2R "Robotic assistance for human movements." The integrated project PI3 "ASSISTMOV," composed of a multidisciplinary team in engineering and Human and Social Sciences (HSS), targets the use case of employing robotic assistance for the movement of persons with disabilities (PWD). Through the development of a range of exoskeletons (lower and upper limbs), this project aims for a breakthrough technology enabling fluid and robust interaction with a variety of environments and uses (from rehabilitation to daily life).

The proposed study contributes to this objective by exploring the clinical and psychosocial dimensions of the daily use of UL assistance devices. Through interviews and questionnaires, it aims to collect data on their impact in terms of independence in activities of daily living (ADL), satisfaction, quality of life, social participation, as well as social perceptions related to the use of these technical aids. It will make it possible to document the benefits and limitations of existing devices from the users' point of view (patients and informal and/or professional caregivers), by identifying the factors that facilitate or hinder their adoption and by exploring the care pathway, from prescription to daily use. The questionnaires will also allow examination of economic dimensions.

The participants included in this study will be recruited among users already using, in their daily life, an UL movement assistance device. All will be regular users of their device, functionally integrated into their usual environment for at least two months. Only devices benefiting from CE marking, guaranteeing their compliance with European regulations, will be eligible. No equipment will be specifically provided within the framework of this research: each participant will share their experience with their own device, as it is integrated into their ADL. A preliminary literature review helped identify the main categories of UL movement assistance devices, grouped according to the following typologies: grasping gloves, mealtime aids, robotic manipulation arms, and arm supports (electric or mechanical).

The purpose of the approach is both diagnostic and forward-looking. It is diagnostic in that it makes it possible to analyze current practices, real activity, and users' viewpoints, in order to identify elements likely to be improved in the recommendation and use of the devices. It is also forward-looking, since it aims to identify new opportunities, needs, or potential developments, in order to support the thinking of roboticists based on field observations.

Inclusion: FOR PATIENT-USER :; Age ≥ 18 years; Effective use of a CE-marked upper-limb assistance device for at least 60 days; Access to a computer with an internet connection and ability to participate in a videoconference; Having provided free and informed non-opposition, or, where applicable, their legal representative; Cognitive abilities compatible with completing the questionnaires and interviews; Medically stable (no ongoing medical event likely to affect the proper conduct of the study); FOR CAREGIVER-USERS (RELATIVES AND/OR PROFESSIONALS) :; Age ≥ 18 years; Relatives or professionals living with or regularly interacting with the patient-user of an upper-limb assistance device; Access to a computer with an internet connection and ability to participate in a videoconference; Having provided free and informed non-opposition.

Exclusion: FOR PATIENT-USER :; Participant enrolled in another protocol evaluating a technical aid; Insufficient mastery of the French language; FOR CAREGIVER-USERS (RELATIVES AND/OR PROFESSIONALS); Insufficient mastery of the French language; Cognitive impairments preventing understanding of the questions.

ClinicalTrials.gov NCT07429188